These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7535752)

  • 21. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470).
    Yamaoka M; Yamamoto T; Masaki T; Ikeyama S; Sudo K; Fujita T
    Cancer Res; 1993 Sep; 53(18):4262-7. PubMed ID: 7689930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined treatment with TNP-470 and 5-fluorouracil effectively inhibits growth of murine colon cancer cells in vitro and liver metastasis in vivo.
    Ogawa H; Sato Y; Kondo M; Takahashi N; Oshima T; Sasaki F; Une Y; Nishihira J; Todo S
    Oncol Rep; 2000; 7(3):467-72. PubMed ID: 10767353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effects of the angiogenesis inhibitor TNP-470 against carcinomatous peritonitis in mice.
    Tsujimoto H; Hagiwara A; Osaki K; Ohyama T; Sakakibara T; Sakuyama A; Ohgaki M; Imanishi T; Watanabe N; Yamazaki J
    Anticancer Drugs; 1995 Jun; 6(3):438-42. PubMed ID: 7545480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
    Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
    Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.
    Muramaki M; Miyake H; Hara I; Kawabata G; Kamidono S
    J Urol; 2004 Oct; 172(4 Pt 1):1485-9. PubMed ID: 15371876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of CDDP and AGM-1470 chemotherapy against lung metastasis in rat osteosarcoma depends on the timing of combined administration.
    Morishita T; Mii Y; Miyauchi Y; Miura S; Honoki K; Aoki M; Kido A; Tamai S; Tsutsumi M; Konishi Y
    Jpn J Clin Oncol; 1997 Aug; 27(4):236-9. PubMed ID: 9379510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of liver metastasis of human gastric carcinoma by angiogenesis inhibitor TNP-470.
    Shishido T; Yasoshima T; Denno R; Sato N; Hirata K
    Jpn J Cancer Res; 1996 Sep; 87(9):958-62. PubMed ID: 8878459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of fumagillin and its analogue TNP-470 on the function, morphology and angiogenesis of an oestrogen-induced prolactinoma in Fischer 344 rats.
    Stepień H; Grochal M; Zieliński KW; Mucha S; Kunert-Radek J; Kulig A; Stawowy A; Pisarek H
    J Endocrinol; 1996 Jul; 150(1):99-106. PubMed ID: 8708569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TNP-470 antiangiogenic therapy for advanced murine neuroblastoma.
    Nagabuchi E; VanderKolk WE; Une Y; Ziegler MM
    J Pediatr Surg; 1997 Feb; 32(2):287-93. PubMed ID: 9044139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
    Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
    Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of an anti-angiogenic agent, TNP-470, on the growth of oral squamous cell carcinomas.
    Ueda N; Kamata N; Hayashi E; Yokoyama K; Hoteiya T; Nagayama M
    Oral Oncol; 1999 Nov; 35(6):554-60. PubMed ID: 10705089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (AGM-1470) on osteosarcoma growth and lung metastasis in rats.
    Morishita T; Mii Y; Miyauchi Y; Miura S; Honoki K; Aoki M; Kido A; Tamai S; Tsutsumi M; Konishi Y
    Jpn J Clin Oncol; 1995 Apr; 25(2):25-31. PubMed ID: 7745819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of the angiogenesis inhibitor TNP-470 on murine lymphoma/leukemia cells in vivo and in vitro.
    Norén-Nyström U; Eriksson M; Eriksson B; Roos G; Bergh A; Holmberg D
    Exp Hematol; 2003 Feb; 31(2):143-9. PubMed ID: 12591279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells.
    Farinelle S; Malonne H; Chaboteaux C; Decaestecker C; Dedecker R; Gras T; Darro F; Fontaine J; Atassi G; Kiss R
    J Pharmacol Toxicol Methods; 2000; 43(1):15-24. PubMed ID: 11091126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.
    Beecken WD; Fernandez A; Panigrahy D; Achilles EG; Kisker O; Flynn E; Joussen AM; Folkman J; Shing Y
    Urology; 2000 Sep; 56(3):521-6. PubMed ID: 10962337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary study in experimental antiangiogenic therapy of nasopharyngeal carcinoma with AGM-1470 (TNP-470).
    Qian CN; Min HQ; Lin HL; Hong MH; Ye YL
    J Laryngol Otol; 1998 Sep; 112(9):849-53. PubMed ID: 9876375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice.
    Kato T; Sato K; Kakinuma H; Matsuda Y
    Cancer Res; 1994 Oct; 54(19):5143-7. PubMed ID: 7522956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenesis inhibitor, TNP-470, suppresses growth of peritoneal disseminating foci.
    Yoshikawa T; Yanoma S; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2000; 47(31):298-302. PubMed ID: 10690624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressive effect of the angiogenesis inhibitor TNP-470 on the development of carcinogen-induced hepatic nodules in rats.
    Ikebe T; Yamamoto T; Kubo S; Hirohashi K; Kinoshita H; Kaneda K; Sakurai M
    Jpn J Cancer Res; 1998 Feb; 89(2):143-9. PubMed ID: 9548441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth.
    Hotz HG; Reber HA; Hotz B; Sanghavi PC; Yu T; Foitzik T; Buhr HJ; Hines OJ
    J Gastrointest Surg; 2001; 5(2):131-8. PubMed ID: 11331474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.